Discover Syntara’s latest Phase 2a trial results for amsulostat in myelofibrosis, showing breakthrough symptom relief and strong pipeline updates.

Syntara Limited ( OTCPK:PMXSF) Shareholder/Analyst Call September 29, 2025 9:00 PM EDT ...

Trump EPA started 14 lawsuits against companies for environmental violations, the fewest in any six-month period this century and below Biden numbers ...

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...

This important study demonstrates that ocular organoids can generate both retina and lens through a non-canonical, "inside-out" morphogenetic route. The work is solid, with well-designed experiments ...

Unless lawmakers or the governor act, provider rate cuts will take effect Wednesday, jeopardizing access to services across the state.

Honda R&D Co. Ltd., headquartered in Waco, Japan, has developed a new chemical sorting technology designed to sort and ...

The challenge of managing relapsed or refractory B-cell malignancies continues to thwart the efforts of oncologists and ...

• Another brutal day for the Americans: Team USA only took one point in the first match as the Europeans grabbed the other three in the morning. Captain Keegan Bradley and gang could not shift the ...

Europe made a late switch to its Saturday afternoon lineup at the Ryder Cup because Viktor Hovland had neck pain, an injury ...

Genetic testing can identify patients with HPV-positive throat cancer who may benefit from lower radiation doses, according ...

Meanwhile, similar experiments appear to have occurred with the China National Space Agency (CNSA). Between July 2 and July 6 ...